ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,822,000 | +83.0% | 82,500 | -3.7% | 0.48% | +69.0% |
Q1 2019 | $2,088,000 | 0.0% | 85,645 | 0.0% | 0.28% | 0.0% |
Q4 2018 | $2,088,000 | 0.0% | 85,645 | 0.0% | 0.28% | 0.0% |
Q3 2018 | $2,088,000 | -12.0% | 85,645 | -39.5% | 0.28% | -10.5% |
Q2 2018 | $2,374,000 | +2.8% | 141,470 | 0.0% | 0.31% | +4.0% |
Q1 2018 | $2,309,000 | +27.5% | 141,470 | 0.0% | 0.30% | +27.4% |
Q4 2017 | $1,811,000 | +4.1% | 141,470 | 0.0% | 0.24% | -1.7% |
Q3 2017 | $1,740,000 | +47.0% | 141,470 | 0.0% | 0.24% | +35.4% |
Q2 2017 | $1,184,000 | -6.4% | 141,470 | 0.0% | 0.18% | -3.3% |
Q1 2017 | $1,265,000 | +1.7% | 141,470 | 0.0% | 0.18% | -2.1% |
Q4 2016 | $1,244,000 | +8.4% | 141,470 | -16.8% | 0.19% | +13.3% |
Q3 2016 | $1,148,000 | +89.8% | 170,000 | 0.0% | 0.17% | +78.5% |
Q2 2016 | $605,000 | +20.5% | 170,000 | 0.0% | 0.09% | +9.4% |
Q1 2016 | $502,000 | -30.0% | 170,000 | 0.0% | 0.08% | -33.1% |
Q4 2015 | $717,000 | -7.5% | 170,000 | 0.0% | 0.13% | -5.2% |
Q3 2015 | $775,000 | -36.8% | 170,000 | 0.0% | 0.13% | -23.9% |
Q2 2015 | $1,226,000 | -2.2% | 170,000 | 0.0% | 0.18% | +6.0% |
Q1 2015 | $1,253,000 | +55.8% | 170,000 | 0.0% | 0.17% | +56.6% |
Q4 2014 | $804,000 | +32.5% | 170,000 | 0.0% | 0.11% | +27.7% |
Q3 2014 | $607,000 | -21.7% | 170,000 | 0.0% | 0.08% | -20.2% |
Q2 2014 | $775,000 | -3.0% | 170,000 | 0.0% | 0.10% | -11.9% |
Q1 2014 | $799,000 | -11.4% | 170,000 | -5.6% | 0.12% | -19.7% |
Q4 2013 | $902,000 | – | 180,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |